USD 0.2
(17.58%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 793.6 Thousand USD | 16.46% |
2022 | 619.51 Thousand USD | -7.64% |
2021 | 670.74 Thousand USD | 1239.01% |
2020 | 50.09 Thousand USD | 0.0% |
2019 | - USD | 100.0% |
2018 | -27.37 Thousand USD | -141.1% |
2017 | -11.35 Thousand USD | 51.15% |
2016 | -23.24 Thousand USD | 96.78% |
2015 | -722.11 Thousand USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | -100.0% |
2001 | 619 Thousand USD | -69.03% |
2000 | 1.99 Million USD | 71.88% |
1999 | 1.16 Million USD | 59.32% |
1998 | 730 Thousand USD | 461.54% |
1997 | 130 Thousand USD | 160.0% |
1996 | 50 Thousand USD | -61.54% |
1995 | 130 Thousand USD | 0.0% |
1994 | - USD | 0.0% |
1993 | - USD | -100.0% |
1992 | 900 Thousand USD | 8900.0% |
1991 | 10 Thousand USD | -66.67% |
1990 | 30 Thousand USD | -25.0% |
1989 | 40 Thousand USD | -60.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 268.13 Thousand USD | 55.98% |
2024 Q2 | 276.41 Thousand USD | 9.81% |
2023 Q1 | 187.34 Thousand USD | 38.76% |
2023 Q4 | 171.89 Thousand USD | -9.29% |
2023 Q3 | 189.51 Thousand USD | -16.45% |
2023 Q2 | 226.82 Thousand USD | 21.08% |
2023 FY | 721.49 Thousand USD | 16.46% |
2022 Q4 | 135.01 Thousand USD | 7.49% |
2022 FY | 619.51 Thousand USD | -7.64% |
2022 Q1 | 188.68 Thousand USD | 9.09% |
2022 Q2 | 170.2 Thousand USD | -9.79% |
2022 Q3 | 125.6 Thousand USD | -26.2% |
2021 Q3 | 157.08 Thousand USD | -24.16% |
2021 FY | 670.74 Thousand USD | 1239.01% |
2021 Q4 | 172.96 Thousand USD | 10.11% |
2021 Q2 | 207.12 Thousand USD | 55.05% |
2021 Q1 | 133.57 Thousand USD | 166.66% |
2020 FY | 50.09 Thousand USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q4 | 50.09 Thousand USD | 0.0% |
2019 Q2 | - USD | 100.0% |
2019 Q1 | -10.32 Thousand USD | 62.29% |
2019 Q4 | - USD | 0.0% |
2019 FY | - USD | 100.0% |
2019 Q3 | - USD | 0.0% |
2018 Q2 | -22.48 Thousand USD | -710.42% |
2018 Q3 | -9426.00 USD | 58.07% |
2018 FY | -27.37 Thousand USD | -141.1% |
2018 Q4 | -27.37 Thousand USD | -190.46% |
2018 Q1 | -2774.00 USD | 75.57% |
2017 Q4 | -11.35 Thousand USD | -300.42% |
2017 Q3 | -2836.00 USD | -1.11% |
2017 Q1 | -2879.00 USD | 87.62% |
2017 Q2 | -2805.00 USD | 2.57% |
2017 FY | -11.35 Thousand USD | 51.15% |
2016 Q3 | -3638.00 USD | -24.8% |
2016 Q4 | -23.24 Thousand USD | -539.03% |
2016 FY | -23.24 Thousand USD | 96.78% |
2016 Q1 | -13.59 Thousand USD | 98.12% |
2016 Q2 | -2915.00 USD | 78.56% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | -722.11 Thousand USD | 0.0% |
2015 Q4 | -722.11 Thousand USD | -5.09% |
2015 Q3 | -687.1 Thousand USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q1 | - USD | 100.0% |
2003 Q2 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2002 Q2 | -288 Thousand USD | -785.71% |
2002 Q3 | - USD | 100.0% |
2002 Q4 | -394 Thousand USD | 0.0% |
2002 FY | - USD | -100.0% |
2002 Q1 | 42 Thousand USD | 7.69% |
2001 Q1 | 331 Thousand USD | -6.23% |
2001 FY | 619 Thousand USD | -69.03% |
2001 Q2 | 243 Thousand USD | -26.59% |
2001 Q3 | 6000.00 USD | -97.53% |
2001 Q4 | 39 Thousand USD | 550.0% |
2000 Q2 | 429 Thousand USD | -51.31% |
2000 FY | 1.99 Million USD | 71.88% |
2000 Q4 | 353 Thousand USD | 5.06% |
2000 Q3 | 336 Thousand USD | -21.68% |
2000 Q1 | 881 Thousand USD | 363.68% |
1999 FY | 1.16 Million USD | 59.32% |
1999 Q1 | 210 Thousand USD | 10.53% |
1999 Q2 | 230 Thousand USD | 9.52% |
1999 Q3 | 210 Thousand USD | -8.7% |
1999 Q4 | 190 Thousand USD | -9.52% |
1998 Q4 | 190 Thousand USD | -20.83% |
1998 Q1 | 70 Thousand USD | -41.67% |
1998 Q2 | 220 Thousand USD | 214.29% |
1998 Q3 | 240 Thousand USD | 9.09% |
1998 FY | 730 Thousand USD | 461.54% |
1997 Q1 | 10 Thousand USD | -50.0% |
1997 FY | 130 Thousand USD | 160.0% |
1997 Q4 | 120 Thousand USD | 0.0% |
1997 Q3 | - USD | 0.0% |
1997 Q2 | - USD | -100.0% |
1996 Q1 | 20 Thousand USD | -84.62% |
1996 Q4 | 20 Thousand USD | 100.0% |
1996 Q3 | 10 Thousand USD | 0.0% |
1996 Q2 | 10 Thousand USD | -50.0% |
1996 FY | 50 Thousand USD | -61.54% |
1995 Q4 | 130 Thousand USD | 0.0% |
1995 FY | 130 Thousand USD | 0.0% |
1995 Q2 | - USD | 0.0% |
1995 Q1 | - USD | 0.0% |
1995 Q3 | - USD | 0.0% |
1994 FY | - USD | 0.0% |
1994 Q1 | - USD | 0.0% |
1994 Q4 | - USD | 0.0% |
1994 Q3 | - USD | 0.0% |
1994 Q2 | - USD | 0.0% |
1993 Q3 | - USD | 0.0% |
1993 Q4 | - USD | 0.0% |
1993 Q1 | - USD | 0.0% |
1993 FY | - USD | -100.0% |
1993 Q2 | - USD | 0.0% |
1992 Q3 | - USD | 0.0% |
1992 Q1 | 900 Thousand USD | 8900.0% |
1992 FY | 900 Thousand USD | 8900.0% |
1992 Q2 | - USD | -100.0% |
1992 Q4 | - USD | 0.0% |
1991 Q1 | - USD | 0.0% |
1991 Q2 | - USD | 0.0% |
1991 Q4 | 10 Thousand USD | 0.0% |
1991 Q3 | - USD | 0.0% |
1991 FY | 10 Thousand USD | -66.67% |
1990 Q2 | - USD | -100.0% |
1990 FY | 30 Thousand USD | -25.0% |
1990 Q3 | - USD | 0.0% |
1990 Q4 | - USD | 0.0% |
1990 Q1 | 30 Thousand USD | 0.0% |
1989 FY | 40 Thousand USD | -60.0% |
1989 Q4 | 30 Thousand USD | 0.0% |
1989 Q3 | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
CVR Medical Corp. | - USD | -Infinity% |
BioElectronics Corporation | 466.38 Thousand USD | -70.16% |
IR-Med Inc. | -17 Thousand USD | 4768.276% |
Polarean Imaging plc | 335.48 Thousand USD | -136.557% |
Medical Supply International USA, Inc. | 1.75 Million USD | 54.875% |
Avitar, Inc. | 836.7 Thousand USD | 5.151% |
AVITA Medical, Inc. | 41.68 Million USD | 98.096% |
Manhattan Scientifics, Inc. | -1000.00 USD | 79460.7% |
Össur hf. | 485.57 Million USD | 99.837% |
Zecotek Photonics Inc. | -195.32 Thousand USD | 506.309% |
Wellstar International, Inc. | - USD | -Infinity% |
Össur hf. | 485.57 Million USD | 99.837% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 16.74 Million USD | 95.26% |
Escalon Medical Corp. | 5.14 Million USD | 84.579% |
Aurora Spine Corporation | 8.21 Million USD | 90.335% |
BrainsWay Ltd. | 23.09 Million USD | 96.563% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | 105.1 Thousand USD | -655.075% |
Hamilton Thorne Ltd. | 35.08 Million USD | 97.738% |
Vivos Inc. | -6036.00 USD | 13247.896% |
MicroPort Scientific Corporation | 532.09 Million USD | 99.851% |
Kelyniam Global, Inc. | 2.03 Million USD | 61.023% |
REMSleep Holdings, Inc. | -756.73 Thousand USD | 204.872% |
CYduct Diagnostics, Inc. | 56.59 Thousand USD | -1302.281% |
Nanomix Corporation | -69.45 Thousand USD | 1242.571% |
Theraclion SA | -1.08 Million USD | 173.456% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 587.55 Thousand USD | -35.071% |
Positron Corporation | -353.46 Thousand USD | 324.522% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 1.04 Million USD | 24.093% |
Lombard Medical, Inc. | 955 Thousand USD | 16.9% |
ALR Technologies Inc. | 4945.00 USD | -15948.675% |
Stratec SE | 71.58 Million USD | 98.891% |
Vycor Medical, Inc. | 1.31 Million USD | 39.68% |
Heart Tronics, Inc. | - USD | -Infinity% |
Nu-Med Plus, Inc. | -12.9 Thousand USD | 6251.992% |
Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -284.464% |
SANUWAVE Health, Inc. | 14.36 Million USD | 94.475% |
VMS Rehab Systems, Inc. | -10.44 USD | 7601699.617% |
Guided Therapeutics, Inc. | 36 Thousand USD | -2104.464% |
Ingen Technologies, Inc. | 268.57 Thousand USD | -195.485% |
Odyssey Group International, Inc. | - USD | -Infinity% |
United American Healthcare Corporation | -8000.00 USD | 10020.088% |
ECGI Holdings, Inc. | - USD | -Infinity% |
Capital Group Holdings, Inc. | - USD | -Infinity% |
ADM Tronics Unlimited, Inc. | 1.09 Million USD | 27.461% |
Urologix, Inc. | 6.09 Million USD | 86.975% |
Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
Nexeon MedSystems Inc. | -316.69 Thousand USD | 350.593% |
SS Innovations International, Inc. | 713.44 Thousand USD | -11.236% |
Qualis Innovations, Inc. | - USD | -Infinity% |
Smith & Nephew plc | 3.91 Billion USD | 99.98% |
NIOX Group Plc | 28.13 Million USD | 97.179% |
Fuse Medical, Inc. | 10.73 Million USD | 92.606% |
Broncus Holding Corporation | 7.22 Million USD | 89.019% |
Brain Scientific Inc. | 54.32 Thousand USD | -1360.85% |
Pressure BioSciences, Inc. | 799.56 Thousand USD | 0.745% |
Health Logic Interactive Inc. | - USD | -Infinity% |